AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Blood Glucose Monitoring Devices (SMBG, CGM Lancets) Market 2020-2024 - ResearchAndMarkets.com

October 9, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Oct 9, 2020--

The “Global Blood Glucose Monitoring Devices Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering.

The blood glucose monitoring devices market is poised to grow by $ 15.60 bn during 2020-2024, progressing at a CAGR of 12% during the forecast period.

ADVERTISEMENT

The reports on blood glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of diabetes in the world and availability of reimbursement for BGM devices. In addition, the growing prevalence of diabetes in the world is anticipated to boost the growth of the market as well.

The blood glucose monitoring devices market analysis includes product segment, end-segment segment, and geographical landscapes. This study identifies the technological advances in BGM devices as one of the prime reasons driving the blood glucose monitoring devices market growth during the next few years.

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose monitoring devices market vendors that include Abbott Laboratories, Agamatrix Inc., ARKRAY Inc., Ascensia Diabetes Care Holdings AG, Dexcom Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Medtronic Plc, Sanofi, and Terumo Medical Corp.

Also, the blood glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Key Topics Covered:

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

ADVERTISEMENT

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five force summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • SMBG - Market size and forecast 2019-2024
  • CGM - Market size and forecast 2019-2024
  • Lancets - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by End-user

  • Hospitals and diagnostic laboratories
  • POL
  • Home care settings

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Agamatrix Inc.
  • ARKRAY Inc.
  • Ascensia Diabetes Care Holdings AG
  • Dexcom Inc.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Medtronic Plc
  • Sanofi
  • Terumo Medical Corp.

Appendix

For more information about this report visit https://www.researchandmarkets.com/r/opunn7

View source version on businesswire.com:https://www.businesswire.com/news/home/20201009005400/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: DIABETES GENERAL HEALTH HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 10/09/2020 10:44 AM/DISC: 10/09/2020 10:44 AM

http://www.businesswire.com/news/home/20201009005400/en